Literature DB >> 19471993

Imaging of a carotid aneurysm in two patients following extracorporeal membrane oxygenation therapy.

Andrew W Duncan1, John B Mawson, Jacques G LeBlanc, James E Potts, Walter J Duncan.   

Abstract

Following extracorporeal membrane oxygenation (ECMO), two patients subsequently developed carotid aneurysms at the site of cannulation. Given the invasive nature of ECMO, vascular ultrasound and/or computerized tomographic imaging should be considered to rule out cannulation-site complications post-ECMO.

Entities:  

Mesh:

Year:  2009        PMID: 19471993     DOI: 10.1007/s00246-009-9462-x

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  4 in total

1.  Rupture of the common carotid artery after extracorporeal membrane oxygenation.

Authors:  Galia Grisaru-Soen; John G Coles; Brian P Kavanagh; Sandra R Arnold
Journal:  Ann Thorac Surg       Date:  2002-11       Impact factor: 4.330

2.  Carotid artery pseudoaneurysm as a complication of ECMO.

Authors:  J P Jacobs; A P Goldman; S Cullen; D Rocco; U Samanli; D J Macrae; M J Elliott
Journal:  Ann Vasc Surg       Date:  1997-11       Impact factor: 1.466

3.  Extracorporeal membrane oxygenation for cardiopulmonary failure in pediatric patients: is a second course justified?

Authors:  Jason C Fisher; Charles J H Stolar; Robert A Cowles
Journal:  J Surg Res       Date:  2008-04-10       Impact factor: 2.192

4.  Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock.

Authors:  Alain Combes; Pascal Leprince; Charles-Edouard Luyt; Nicolas Bonnet; Jean-Louis Trouillet; Philippe Léger; Alain Pavie; Jean Chastre
Journal:  Crit Care Med       Date:  2008-05       Impact factor: 7.598

  4 in total
  1 in total

1.  Successful primary use of VVDL+V ECMO with cephalic drain in neonatal respiratory failure.

Authors:  J Roberts; S Keene; M Heard; C McCracken; T W Gauthier
Journal:  J Perinatol       Date:  2015-11-12       Impact factor: 2.521

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.